Summary of Financial Results for Fiscal Year Ended March 31, 2021

May 13, 2021
Sawai News

Share:

Press Release

Sawai Receives Approvals for Eight Generic Drugs with 20 Strengths
FY2020 Financial Results for fiscal year ended March 31, 2021

Imagining What's Next in Generics

At Upsher-Smith, our heritage is generic pharmaceuticals.

We have recently committed ourselves to aggressively growing the number of generic development programs in our pipeline. Over the next few years, through both internal research and external partnerships, we will substantially expand our generic product portfolio.

Learn More About Our Products

Site Credits
Terms and Conditions
Privacy Policy
Accessibility
Legal Notices